MPN Advocacy posted on LinkedIn:
“Thank you to Ruben Mesa, Abdulraheem Yacoub, Tsewang Tashi, Wanxing Chai-Ho, Chang Ho Yoon, and John Mascarenhas for creating this dialogue with the peginterferon Alfa-2a shortages that are impacting MPN patients worldwide.”
“Navigating the peginterferon Alfa-2a shortage: practical guidance on transitioning patients to ropeginterferon alfa-2b.”
Authors: Ruben Mesa, Abdulraheem Yacoub, Tsewang Tashi, Wanxing Chai-Ho, Chang Ho Yoon, and John Mascarenhas
